Trial intelligence / Profile preview

Co-enzyme Q10 versus placebo for tinnitus due to presbycusis

IRCT20120215009014N339Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in tinnitus and presbycusis comparing Coenzyme Q10 with Placebo (2 arms). Started Sep 2019; status: completed.

02

Drugs

coenzyme q10
03

Conditions

tinnituspresbycusis

Beyond the preview

Go deeper on IRCT20120215009014N339.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120215009014N339.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call